These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 9413223

  • 1. Pharmacokinetics of platinum following the administration of cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in dogs.
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1997; 17(5A):3681-3. PubMed ID: 9413223
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogs.
    Kim DK, Cho YB, Kim HT, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996; 16(3A):1167-9. PubMed ID: 8702230
    [Abstract] [Full Text] [Related]

  • 3. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.
    Kim DK, Kim HT, Tai JH, Cho YB, Kim TS, Kim KH, Park JG, Hong WS.
    Cancer Chemother Pharmacol; 1995; 37(1-2):1-6. PubMed ID: 7497577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
    Ota K, Oguma T, Shimamura K.
    Anticancer Res; 1994; 14(3B):1383-7. PubMed ID: 8067710
    [Abstract] [Full Text] [Related]

  • 13. cis-[(4R,5R)-4,5-bis(aminomethyl)-2,2-dimethyl-1,3-dioxolane-N,N']- (malonato-O,O')platinum(II), an anticancer agent.
    Cho SW, Cho Y, Kim DK, Shin W.
    Acta Crystallogr C; 2000 Jun; 56(Pt 6):653-4. PubMed ID: 10902008
    [No Abstract] [Full Text] [Related]

  • 14. A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies.
    Kim NK, Kim TY, Shin SG, Park YI, Lee JA, Cho YB, Kim KH, Kim DK, Heo DS, Bang YJ.
    Cancer; 2001 Apr 15; 91(8):1549-56. PubMed ID: 11301404
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
    Wang X, Au-Yeung SC, Ho YP.
    J Inorg Biochem; 2007 Jun 15; 101(6):909-17. PubMed ID: 17428541
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):367-74. PubMed ID: 11976830
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
    Baur M, Drescher A, Gneist M, Dittrich C, Jaehde U.
    Cancer Chemother Pharmacol; 2008 Jan 15; 61(1):97-104. PubMed ID: 17396265
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.